Point72 Asset Management
GHDX

Point72 Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Point72 Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,600
Closed -$93K – 1620
2019
Q2 		$93K Buy
+1,600
New +$94.8K ﹤0.01% 1065
2018
Q2 		– Sell
-388,400
Closed -$12.2M – 1275
2018
Q1 		$12.2M Buy
388,400
+223,800
+136% +$7.43M 0.05% 385
2017
Q4 		$5.63M Buy
164,600
+153,700
+1,410% +$4.9M 0.02% 569
2017
Q3 		$350K Buy
+10,900
New +$344K ﹤0.01% 810

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Point72 Asset Management's GHDX Position: Q3 2019 in Review

Point72 Asset Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 1,600 shares — an estimated $93K sold.

Point72 Asset Management first reported a position in GHDX in Q3 2017 and held it in 4 quarters. The position peaked at $12.2M in Q1 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Point72 Asset Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Point72 Asset Management sold 1,600 Genomic Health, Inc. shares in Q3 2019, an estimated $93K.
  • Point72 Asset Management first reported a position in Genomic Health, Inc. in Q3 2017 and held it in 4 quarters.
  • Point72 Asset Management's Genomic Health, Inc. position peaked at $12.2M in Q1 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Point72 Asset Management's 13F filing for Q3 2019, filed 15 Nov 2019.